BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3724021)

  • 1. [Therapeutic effectiveness of ziksorin in hyperbilirubinemia and hypercortisolism].
    Demin AA; Zhuk RD; Smirnov VV; Ruiatkina LA
    Klin Med (Mosk); 1986 Apr; 64(4):92-4. PubMed ID: 3724021
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ziksorin in the combined treatment of psoriasis].
    Kipnis VM
    Vestn Dermatol Venerol; 1990; (4):73. PubMed ID: 2389616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxicity and therapeutic utility of DDT and its metabolites].
    Greim H
    Arztl Forsch; 1970 Jul; 24(7):197-201. PubMed ID: 5468108
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ziksorin in the treatment of unconjugated familial functional jaundice--the Gilbert-Meulengracht syndrome].
    Kolarski V; Petrova-Shopova K
    Vutr Boles; 1989; 28(1):90-3. PubMed ID: 2741447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness of using the enzyme inducer zixorin in the complex treatment of patients with viral hepatitis A].
    Gnoevoĭ VB; Maksin VR; Zaika VI; Mosichev IuN
    Voen Med Zh; 1989 Jun; (6):38-9. PubMed ID: 2800400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of phenobarbital, ziksorin and cordiamine in the treatment of non-conjugated hyperbilirubinemia].
    Vasil'ev VS; Tsyrkunov VM; Bogutskiĭ MI; Bushma MI; Abakumov GZ
    Klin Med (Mosk); 1989 Apr; 67(4):52-4. PubMed ID: 2666736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The correction of the liver detoxifying function with phenobarbital and ziksorin before and after ischemia].
    Grek OR; Rybakova TA; Sharapov VI; Zakharova MV; Shkurupiĭ VA
    Eksp Klin Farmakol; 1993; 56(5):30-3. PubMed ID: 8312805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and the liver.
    Black M
    Trans Med Soc Lond; 1970; 86():81-6. PubMed ID: 5531298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Enzyme induction in the liver--its mechanism and clinical significance].
    Yamamoto T; Iwasaki Y; Adachi Y
    Nihon Rinsho; 1972 Sep; 30(9):1952-65. PubMed ID: 4568205
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arrhythmia in patients with chronic ischemic heart disease using kinilentin combined with an inhibitor or inductor of microsomal oxidation].
    Kharlamova IV; Sivkov II; Starodubtsev AK; Bogovskiĭ BP; Blinkov IL; Rubin MP
    Sov Med; 1989; (12):41-4. PubMed ID: 2631246
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use].
    Bricaire H; Luton JP
    Therapie; 1974; 29(5):645-58. PubMed ID: 4462221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Osteopathies associated with hypercortisolism and vitamin D metabolism].
    Wilczek H; Pacovský V; Justová V
    Sb Lek; 1984 Jul; 86(7):209-12. PubMed ID: 6494797
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic possibilities using the induction of drug reducing enzymes].
    Greim H
    Dtsch Med Wochenschr; 1970 Oct; 95(43):2196-9. PubMed ID: 4097836
    [No Abstract]   [Full Text] [Related]  

  • 14. Zixoryn--a new Hungarian enzyme inducing preparation (results in the treatment of neonatal icterus).
    Boross G; Korányi G
    Ther Hung; 1986; 34(4):224-6. PubMed ID: 3449977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol and cortisol binding characteristics in girls with "cushingoid" syndrome.
    Krawczuk A; Sipowicz I; Sikorski TK
    Endokrinologie; 1973 Dec; 62(3):350-8. PubMed ID: 4790814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the effect of zixoryn and phenobarbital on the toxicity of anthracycline antibiotics and liver monooxygenase activity in mice].
    Bogush TA; Sitdikova SM; Syrkin AB
    Vestn Akad Med Nauk SSSR; 1985; (11):82-6. PubMed ID: 4090659
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydrocortisone suppression test for Cushing syndrome. Therapy with anticonvulsants.
    Meikle AW; Stanchfield JB; West CD; Tyler FH
    Arch Intern Med; 1974 Dec; 134(6):1068-71. PubMed ID: 4372963
    [No Abstract]   [Full Text] [Related]  

  • 19. Trilostane for Cushing's syndrome.
    Med Lett Drugs Ther; 1985 Oct; 27(698):87-8. PubMed ID: 4046969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of microsomal monooxygenase inductor zixoryn on clinico-immunologic indicators in allergologic patients].
    Lozovoĭ VP; Vol'skii NN; Nepomniashchikh VM; Tananko EM; Nosikova TA
    Ter Arkh; 1987; 59(2):7-9. PubMed ID: 3576481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.